Home > Investors
Investors
Investors
Please follow this link to learn more about the acquisition of Cellartis.
Shareholders InformationFind general information on this page dedicated to shareholders, and read the lastest editions of the Letter to Shareholders. |
Contacts
Investissement |
Overview
- Incorporated:January 2000
- Stock exchange:Alternext by NYSE-Euronext, Paris
- Ticker code:ALCLSISIN code: FR0010425595
- Number of outstanding shares: 14.128.446
- Listing date: 7 February 2007
- Activity: Cellectis develops high-precision, high-performance systems for DNA surgery and cell reprogramming.
- Legal form: French "Société Anonyme" (SA) with a Board of Directors
- Chief Executive Officer: André Choulika PhD
- Number of employees: 210 including 75 PhD
- Corporate HQ and laboratories: 8, rue de la Croix-Jarry, 75013 Paris